Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
EUDA Health Holdings Limited - SIC # 6510 -
Ticker
Exchange
SIC #
Website
Latest Ticker
EUDA
Nasdaq
6510
eudahealth.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for EUDA Health Holdings Limited
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
- Aug 26th, 2026 4:00 am
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
- Jul 30th, 2026 4:00 am
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
- Jul 28th, 2026 4:00 am
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
- Jun 1st, 2026 4:05 am
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
- Jun 1st, 2026 4:00 am
EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development
- Apr 28th, 2026 4:00 am
EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities
- Apr 27th, 2026 4:00 am
EUDA Health price target lowered to $2.75 from $6 at Greenridge
- Mar 10th, 2026 8:00 am
EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital
- Dec 30th, 2025 5:00 am
Top Midday Gainers
- Dec 23rd, 2025 11:44 am
EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen
- Dec 23rd, 2025 5:00 am
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement
- Dec 5th, 2025 7:30 am
Scroll